Opuholi Golovy i Sei

Aims & Scope

The main objective of the journal Head and Neck Tomors is to publish the latest clinical research data, as well as the information on the diagnosis and treatment of the diseases.

The aim of the journal is to inform the specialists in head and neck tumors about the latest achievements in this area, to emphasize the importance of an integrated and multidisciplinary approach to therapy, to unite different specialists (radiologists, neurosurgeons, chemotherapeutists, etc.), thus, assisting to improve treatment efficacy in patients with head and neck tumors.

The collaboration of specialists allows developing a unified strategy for scientific and clinical research, diagnosis and treatment of the diseases.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology and Medicine, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Tafalgin is a Russian innovative tetrapeptide pharmaceutical for subcutaneous injection: review of the results of phase I and II clinical trials

  Citation: 21

  Authors: V. S., G. R., E. R., O. Yu., K. A.

• Dermatologic adverse events associated with epidermal growth factor receptor inhibitors: current concepts of interdisciplinary problem

  Citation: 9

  Authors: A. S., E. A., L. S.

• Current aspects of treatment and rehabilitation of patients with pharyngeal cancer

  Citation: 8

  Authors: A. L.

• HPV-negative oropharyngeal carcinoma as a separate prognostkally unfavorable form of cancer, requiring new approaches to treatment (case report)

  Citation: 7

  Authors: A. R., A. V., A. P., L. V., N. N., I. V., A. М., S. V.

• Treatment policy for localized oral cancer

  Citation: 7

  Authors: I. M., I. S., D. B.

• Esthesioneuroblastoma: clinical course, long-term results of treatment

  Citation: 6

  Authors: T. D., A. M., S. B., N. F., L. E., E. R., I. N., R. A., T. A., N. A.

• Efficacy and tolerability of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer: results of a multicenter observational study in the Russian Federation

  Citation: 6

  Authors: E. V., P. A., A. Yu., P. O., V. V., K. M., A. D., S. A., S. O., I. S., A. M., K. Yu., R. S., M. V., R. M., I. R., A. I., A. Kh., N. L., A. R., L. P., E. V., E. M., O. A., A. E., F. F., E. S., Yu. V., Sh. I., M. R., A. I., S. Z., S. L.

• APPLICATION OF 3D MODELING IN 3D PRINTING FOR THE LOWER JAW RECONSTRUCTION

  Citation: 6

  Authors: Yu. Yu., V. A., M. A., V. Yu.

• RECONSTRUCTION OF POSTOPERATIVE DEFECTS AFTER REMOVAL OF HYPOPHARYNGEAL AND CERVICAL ESOPHAGEAL TUMORS

  Citation: 6

  Authors: T. V., A. M., A. V.

• Human papillomavirus in head and neck cancer (literature review)

  Citation: 6

  Authors: A. M., M. M., M. K., N. V.